Altered expression of dopamine transporter in substantia nigra and striatum in postmortem human brain of Parkinson's disease

Chinese Journal of Neurology

Volumn 38, Issue 8, 2005, Pages 495-497

  Shi, Ge Ming ^a   Li, Shuang Cheng ^b   Wang, Zhi Hong ^b   Wang, Wei ^b   Cui, Hui Xian ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Corpus striatum; Membrane transport proteins; Nerve tissue proteins; Parkinson disease; Substantia nigra

Indexed keywords

ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; HUMAN CELL; HUMAN TISSUE; PARKINSON DISEASE; PUTAMEN; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; ZONA INCERTA;

EID: 28344435357     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Miller GW, Heilman CJ, Perez JT, et al. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol, 1997, 41: 530-539.
2. Counihan TJ, Penney JB Jr. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains. J Neurol Neurosurg Psychiatry, 1998, 65: 164-169.
3. 123Ibeta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin, 2003, 42: 31-38.
4. Hersch SM, Yi H, Heilman CJ, et al. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol, 1997, 388: 211-227.
5. Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience, 2000, 96: 451-474.
6. Zhang K, Davids E, Tarazi FI, et al. Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Dev Brain Res, 2002, 137: 135-138.
7. Haycock JW, Becker L, Ang L, et al. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem, 2003, 87: 574-585.
8. Lvatore MF, Apparsundaram S, Gerhardt GA. Decreased plasma membrane expression of striatal dopamine transporter in aging. Neurobiol Aging, 2003, 24: 1147-1154.